Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results
Conference Call October 20, 8:45am ESTQUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (NASDAQ: DCTH),…
Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint
Conference Call October 20, 8:45am ESTQUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (NASDAQ: DCTH),…
Akums Reports Q4 FY25 with 12.4% Revenue Growth, FY25 Adj. EBITDA Remained Strong at 12.3%
Akums Drugs and Pharmaceuticals Ltd., India’s largest contract development and manufacturing organization…
Synaptics to Report First Quarter Fiscal 2026 Results on November 6, 2025
SAN JOSE, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA)…
Starburst Announces Winners of the 2025 Data Visionary Awards
Awards honor customers and partners who are redefining what's possible with data…
Euro NCAP to Launch New 2025 Car Safety Results
WhatLatest Euro NCAP results published online and via social media.WhenWednesday 15 October…
EverQuote to Announce Third Quarter 2025 Financial Results on November 3, 2025
October 13, 2025 16:10 ET | Source: EverQuote, Inc. CAMBRIDGE, Mass., Oct.…
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress
The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal…
NTG Nordic Transport Group A/S – Q3 2025 Conference Call
October 10, 2025 04:00 ET | Source: NTG Nordic Transport Group A/S…
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinsons disease
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at…